AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II)
Authors: Albers, GW Bogousslavsky, J Bozik, MA Brass, LM Broderick, JP Fisher, M Goldstein, LB Salazar-Grueso, E Akitsuki, S Aranko, K Ashwood, T Atkinson, RP Bell, RD Brott, TG Cady, WJ Caplan, LR Coggins, S Cramer, S Cyrus, P Dayno, J Easton, JD Elliott, PJ Finklestein, SP Furlan, AJ Gamzu, E Glasky, MS Gordon, K Gorelick, PB Greenwood, DT Grotta, JC Gunn, K Hachinski, V Hacke, W Hall, ED Hsu, CY Humphreys, DM Ishikawa, H Jacobs, AJ Kaste, M Koroshetz, WJ Krams, M Lauritano, AA Leclerc, J Lees, KR Lesko, L Levine, SR Levy, DE Li, FH Lyden, PD Masayasu, H McDermott, J Meibach, RC Meya, U Miyairi, K Niidome, T Oeda, J Poole, RM Ron, ES Sacco, RL Saltarelli, MD Shimizu, K Shook, BJ Soehngen, M Soehngen, W Stamler, DA Styren, SD Teal, PA Tilley, BC Traystman, RJ Walker, MD Wallin, BA Warach, S Ward, DP Wessel, TC Wettstein, J
Citation: Gw. Albers et al., Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II), STROKE, 32(7), 2001, pp. 1598-1606
Primary prevention of ischemic stroke - A statement for healthcare professionals from the Stroke Council of the American Heart Association
Authors: Goldstein, LB Adams, R Becker, K Furberg, CD Gorelick, PB Hademenos, G Hill, M Howard, G Howard, VJ Jacobs, B Levine, SR Mosca, L Sacco, RL Sherman, DG Wolf, PA del Zoppo, GJ
Citation: Lb. Goldstein et al., Primary prevention of ischemic stroke - A statement for healthcare professionals from the Stroke Council of the American Heart Association, STROKE, 32(1), 2001, pp. 280-299
Ischemic stroke outcome - Racial differences in the trial of danaparoid inacute stroke (TOAST)
Authors: Hassaballa, H Gorelick, PB West, CP Hansen, MD Adams, HP
Citation: H. Hassaballa et al., Ischemic stroke outcome - Racial differences in the trial of danaparoid inacute stroke (TOAST), NEUROLOGY, 57(4), 2001, pp. 691-697
A comparison of stroke risk factors in patients enrolled in stroke prevention trials
Authors: Lynch, GF Leurgans, S Raman, R Barboi, A Gorelick, PB
Citation: Gf. Lynch et al., A comparison of stroke risk factors in patients enrolled in stroke prevention trials, J NAT MED A, 93(3), 2001, pp. 79-86
Should you screen for an aneurysm in a migraineur whose mother died from aruptured intracranial saccular aneurysm?
Authors: Evans, RW Gorelick, PB Rothbart, D
Citation: Rw. Evans et al., Should you screen for an aneurysm in a migraineur whose mother died from aruptured intracranial saccular aneurysm?, HEADACHE, 41(2), 2001, pp. 204-205
Primary prevention of ischemic stroke - A statement for healthcare professionals from the Stroke Council of the American Heart Association
Authors: Goldstein, LB Adams, R Becker, K Furberg, CD Gorelick, PB Hademenos, G Hill, M Howard, G Howard, VJ Jacobs, B Levine, SR Mosca, L Sacco, RL Sherman, DG Wolf, PA del Zoppo, GJ
Citation: Lb. Goldstein et al., Primary prevention of ischemic stroke - A statement for healthcare professionals from the Stroke Council of the American Heart Association, CIRCULATION, 103(1), 2001, pp. 163-182
Primary and secondary prevention of stroke
Authors: Gorelick, PB
Citation: Pb. Gorelick, Primary and secondary prevention of stroke, DRUG THERAPY FOR STROKE PREVENTION, 2001, pp. 14-34
Autopsy recruitment program for African Americans
Authors: Bonner, GJ Darkwa, OK Gorelick, PB
Citation: Gj. Bonner et al., Autopsy recruitment program for African Americans, ALZ DIS A D, 14(4), 2000, pp. 202-208
Stroke in African Americans
Authors: Lynch, GF Gorelick, PB
Citation: Gf. Lynch et Pb. Gorelick, Stroke in African Americans, NEUROL CLIN, 18(2), 2000, pp. 273
Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?
Authors: Gorelick, PB
Citation: Pb. Gorelick, Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?, LANCET, 355(9219), 2000, pp. 1925-1926
Measuring and improving quality of care - A report from the American HeartAssociation/American College of Cardiology First Scientific Forum on Assessment of healthcare quality in cardiovascular disease and stroke
Authors: Krumholz, HM Brass, LM Every, NR Spertus, JA Bazzarre, T Cohen, DJ Hlatky, MA Peterson, ED Radford, MJ Weintraub, WS Every, NR Cannon, CP Ellerbeck, EF McNeil, BJ Peterson, ED Radford, MJ Ryan, TJ Smith, SC Spertus, JA Krumholz, HM Baker, DW Ashton, CM Dunbar, SB Friesinger, GC Havranek, EP Hlatky, MA Konstam, M Ordin, DL Pina, IL Pitt, B Spertus, JA Spertus, JA DeLong, ER Eagle, RA Normand, SL Mark, DB McAllister, BD Thomas, JW Weintraub, WS Brass, LM Duncan, PW Goldstein, LB Gorelick, PB Hinchey, JA Matchar, DB Nilasena, D Wennberg, D Williams, LS Wolf, PA
Citation: Hm. Krumholz et al., Measuring and improving quality of care - A report from the American HeartAssociation/American College of Cardiology First Scientific Forum on Assessment of healthcare quality in cardiovascular disease and stroke, STROKE, 31(4), 2000, pp. 1002-1012
Measuring and improving quality of care - A report from the American HeartAssociation/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in cardiovascular disease and stroke
Authors: Krumholz, HM Brass, LM Every, NR Spertus, JA Bazzarre, T Cohen, DJ Hlatky, MA Peterson, ED Radford, MJ Weintraub, WS Cannon, CP Ellerbeck, EF McNeil, BJ Peterson, ED Radford, MJ Ryan, TJ Smith, SC Baker, DW Ashton, CM Dunbar, SB Friesinger, GC Havranek, EP Hlatky, MA Konstam, M Ordin, DL Pina, IL Pitt, B DeLong, ER Eagle, KA Normand, SL Mark, DB McAllister, BD Thomas, JW Weintraub, WS Brass, LM Duncan, PW Goldstein, LB Gorelick, PB Hinchey, JA Matchar, DB Nilasena, D Wennberg, D Williams, LS Wolf, PA
Citation: Hm. Krumholz et al., Measuring and improving quality of care - A report from the American HeartAssociation/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in cardiovascular disease and stroke, CIRCULATION, 101(12), 2000, pp. 1483-1493
Plasma lipids and stroke
Authors: Gorelick, PB Mazzone, T
Citation: Pb. Gorelick et T. Mazzone, Plasma lipids and stroke, J CARD RISK, 6(4), 1999, pp. 217-221
Prevention of vascular dementia
Authors: Gorelick, PB Erkinjuntti, T Hofman, A Rocca, WA Skoog, I Winblad, B
Citation: Pb. Gorelick et al., Prevention of vascular dementia, ALZ DIS A D, 13, 1999, pp. S131-S139
Diabetes mellitus and cerebrovascular disease
Authors: Lukovits, TG Mazzone, T Gorelick, PB
Citation: Tg. Lukovits et al., Diabetes mellitus and cerebrovascular disease, NEUROEPIDEM, 18(1), 1999, pp. 1-14
Prevention of a first stroke - A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association
Authors: Gorelick, PB Sacco, RL Smith, DB Alberts, M Mustone-Alexander, L Rader, D Ross, JL Raps, E Ozer, MN Brass, LM Malone, ME Goldberg, S Booss, J Hanley, DF Toole, JF Greewold, NL Rhew, DC
Citation: Pb. Gorelick et al., Prevention of a first stroke - A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association, J AM MED A, 281(12), 1999, pp. 1112-1120
Carotid endarterectomy - Where do we draw the line?
Authors: Gorelick, PB
Citation: Pb. Gorelick, Carotid endarterectomy - Where do we draw the line?, STROKE, 30(9), 1999, pp. 1745-1750
Preventing ischemic stroke in patients with prior stroke and transient ischemic attack - A statement for healthcare professionals from the Stroke Council of the American Heart Association
Authors: Wolf, PA Clagett, GP Easton, JD Goldstein, LB Gorelick, PB Kelly-Hayes, M Sacco, RL Whisnant, JP
Citation: Pa. Wolf et al., Preventing ischemic stroke in patients with prior stroke and transient ischemic attack - A statement for healthcare professionals from the Stroke Council of the American Heart Association, STROKE, 30(9), 1999, pp. 1991-1994
Therapeutic benefit - Aspirin revisited in light of the introduction of clopidogrel
Authors: Gorelick, PB Born, GVR D'Agostino, RB Hanley, DF Moye, L Pepine, CJ
Citation: Pb. Gorelick et al., Therapeutic benefit - Aspirin revisited in light of the introduction of clopidogrel, STROKE, 30(8), 1999, pp. 1716-1721
Recommendations for standards regarding preclinical neuroprotective and restorative drug development
Authors: Feinklestein, SP Fisher, M Furland, AJ Goldstein, LB Gorelick, PB Kaste, M Lees, KR Traystman, RJ Albers, GW Anwer, UE Ashwood, T Barone, FC Basta, SL Bogousslavsky, J Buchan, AM Cady, WJ Chan, PH Clemens, JA Cox, BF Craddock, RE Cramer, SC del Zoppo, GJ Dielrich, WD Elliott, P Faden, AI Feuerstein, GZ Ginsberg, MD Gold, M Greene, WL Hall, ED Hsu, CY Hunter, AJ Lai, M Lesko, LM Levy, DE Li, FH Locke, KW Lodge, D Lowe, D Marcoux, FW McCulloch, J McDermott, J Meibach, R Messersmith, EK Moseley, M Moskowitz, MA Mueller, AL Munro, F Nudo, RJ Oeda, J Ohlstein, EH Parsons, A Patmore, L Poole, RM Pschorn, U Pulsinelli, WA Sacco, RL Saeki, S Salazar-Grueso, E Sandage, BW Schallert, T Schielke, GP Sharkey, J Sotak, CH Steiger, B Storall, S Takahashi, Y Tumas, D Van Bruggen, N Versavel, M Vornov, J Walker, MD Wallin, B Wang, J Warach, S Wells, DS Witcher, JA
Citation: Sp. Feinklestein et al., Recommendations for standards regarding preclinical neuroprotective and restorative drug development, STROKE, 30(12), 1999, pp. 2752-2758
Risk factors and their management for stroke prevention: Outlook for 1999 and beyond
Authors: Sacco, RL Wolf, PA Gorelick, PB
Citation: Rl. Sacco et al., Risk factors and their management for stroke prevention: Outlook for 1999 and beyond, NEUROLOGY, 53(7), 1999, pp. S15-S24
Can we save the brain from the ravages of midlife cardiovascular risk factors?
Authors: Gorelick, PB
Citation: Pb. Gorelick, Can we save the brain from the ravages of midlife cardiovascular risk factors?, NEUROLOGY, 52(6), 1999, pp. 1114-1115
Ischemia in the territory of a hypoplastic vertebrobasilar system
Authors: Chaturvedi, S Lukovits, TG Chen, W Gorelick, PB
Citation: S. Chaturvedi et al., Ischemia in the territory of a hypoplastic vertebrobasilar system, NEUROLOGY, 52(5), 1999, pp. 980-983
Stroke prevention trials: How many enrollees can be expected by site?
Authors: Lukovits, TG Thomas, K Gorelick, PB
Citation: Tg. Lukovits et al., Stroke prevention trials: How many enrollees can be expected by site?, NEUROLOGY, 52(5), 1999, pp. 1101-1102
Lacunar stroke in black patients - Clinical presentation and detection
Authors: Lynch, GFF Washington, J Gorelick, PB
Citation: Gff. Lynch et al., Lacunar stroke in black patients - Clinical presentation and detection, STROKE IN BLACKS, 1999, pp. 19-28
Risultati: 1-25 | 26-27